Rigel Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Rigel Pharmaceuticals Inc share price today is $26.04, up -0.54%. The stock opened at $26 against the previous close of $26.1, with an intraday high of $26.3 and low of $25.65.
Rigel Pharmaceuticals Inc Share Price Chart
Rigel Pharmaceuticals Inc
Rigel Pharmaceuticals Inc Share Price Performance
Rigel Pharmaceuticals Inc Institutional Holdings
Rigel Pharmaceuticals Inc Market Status
Rigel Pharmaceuticals Inc Fundamentals
Market Cap 479.56 M
PB Ratio 1.2316
PE Ratio 1.3354
Enterprise Value 380.50 M
Total Assets 513.59 M
Volume 463552
Rigel Pharmaceuticals Inc Company Financials
About Rigel Pharmaceuticals Inc & investment objective
Company Information Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; REZLIDHIA, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test; and GAVRETO, a once daily, small molecule, oral, kinase inhibitor for the treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC), as well as to treat adult and pediatric patients twelve years of age and older with advanced or metastatic RET fusion-positive thyroid cancer. It also develops R289, an oral interleukin receptor-associated kinases 1 and 4 (IRAK1/4) inhibitor, which is being advanced to Phase 1b study for the treatment of hematology-oncology, autoimmune, and inflammatory diseases, as well as to treat lower-risk myelodysplastic syndrome. The company has strategic development collaboration with The University of Texas MD Anderson Cancer Center (MDACC) for the development of olutasidenib in AML and other hematologic cancers with IDH1mutations; and the Collaborative Network for Neuro-Oncology Clinical Trial (CONNECT) to conduct a Phase 2 clinical trial to evaluate olutasidenib in combination with temozolomide in patients with high-grade glioma harboring an IDH1 mutation. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.
Organisation Biotechnology
Employees 172
Industry Biotechnology
CEO Mr. Raul R. Rodriguez
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Rigel Pharmaceuticals Inc FAQs
What is the share price of Rigel Pharmaceuticals Inc today?
The current share price of Rigel Pharmaceuticals Inc is $26.04.
Can I buy Rigel Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Rigel Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Rigel Pharmaceuticals Inc shares in India?
You can easily invest in Rigel Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Rigel Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Rigel Pharmaceuticals Inc.
Can I buy fractional shares of Rigel Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Rigel Pharmaceuticals Inc?
Rigel Pharmaceuticals Inc has a market cap of $479.56 M.
In which sector does Rigel Pharmaceuticals Inc belong?
Rigel Pharmaceuticals Inc operates in the Biotechnology sector.
What documents are required to invest in Rigel Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Rigel Pharmaceuticals Inc?
The PE ratio of Rigel Pharmaceuticals Inc is 1.34 and the PB ratio is 1.23.